Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Seawater isotonic solution is a sterile, diluted seawater preparation adjusted to a salt concentration of approximately 0.9% (w/v), matching the osmotic pressure of human extracellular fluid and blood plasma. Unlike simple physiological saline (0.9% NaCl), seawater solutions retain a complex profile of trace elements and minerals naturally found in the ocean, such as magnesium, potassium, calcium, and copper. These minerals are thought to provide additional therapeutic benefits, including anti-inflammatory properties and the optimization of ciliary beat frequency. The solution is primarily indicated for nasal hygiene, the relief of nasal congestion associated with rhinitis or sinusitis, and post-operative care. Its mechanism of action is primarily mechanical, involving the irrigation and clearance of mucus, crusts, allergens, and inflammatory mediators from the nasal mucosa, while simultaneously hydrating the epithelium and supporting the natural defense mechanisms of the upper respiratory tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on seawater isotonic solution.